Antiviral treatment initiation costs in chronic hepatitis C

Lignende værker

• Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
  af: Siebert, U, et al.
  Udgivet: (2003)
• Estimating future hepatitis C morbidity, mortality, and costs in the United States.
  af: Wong, J B, et al.
  Udgivet: (2000)
• Treatment Strategies for Nonresponders to Hepatitis C Antiviral Therapy
  af: McHutchison, John
  Udgivet: (2006)
• Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
  af: Siebert, Uwe, et al.
  Udgivet: (2003)
• Cost-Effectiveness of New Antiviral Regimens for Treatment-Naïve US Veterans with Hepatitis C
  af: Chidi, Alexis P., et al.
  Udgivet: (2015)